Migrant health: Sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions
This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the European Union/European Economic Area (EU/EEA). Member states’ surveillance systems for monitoring the sexual transmission of HIV among migrant populations are also profiled.
Based on this evidence, actions are proposed for Member States that wish to improve their surveillance systems to monitor HIV transmission in migrant populations and improve targeted prevention programmes.
This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the European Union/European Economic Area (EU/EEA). The implications of this evidence are summarised and recommendations provided for those Member States that wish to improve their surveillance systems in order to assess the sexual transmission of HIV in their at-risk migrant populations.
In a systematic review of the literature, the report examines the evidence for sexual transmission of HIV among persons from countries with generalised HIV epidemics after they have arrived in Europe. Additionally, a survey of EU/EEA Member States on the subject of sexual transmission of HIV in populations of migrants was conducted.
Given the evidence for ongoing HIV transmission among at-risk migrant groups in some countries of the EU/EEA, the report considers the following actions to address current limitations in HIV surveillance and prevention interventions:
- Policy makers and programme implementers in those countries that identify migrants as important to their HIV epidemic need to:
- be aware that transmission among migrants may be taking place in their countries;
- consider which surveillance variables to collect and analyse in order to better understand and monitor the degree to which sexual transmission of HIV occurs among migrant populations;
- consider developing an evidence-based, long-term strategic policy to reduce post-migration HIV-acquisition and transmission;
- direct additional attention and resources to improve primary prevention programmes targeted to the specific needs of migrants, and
- involve affected migrant communities in developing and delivering migrant-sensitive HIV prevention services.
- As migrant MSM are at particular risk of HIV acquisition and transmission after migrating to the EU/EEA, policies and programmes should be considered that place specific emphasis on this.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.